Marker Therapeutics (MRKR) Operating Margin Growth (3y) (2022 - 2025)
Marker Therapeutics (MRKR) Operating Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -2,649.00 |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,954.00 |
| Sep 30, 2025 | 40,959.00 |
| Jun 30, 2025 | 17,169.00 |
| Mar 31, 2025 | -40,443.00 |
| Jun 30, 2023 | 218,386.00 |
| Dec 31, 2022 | 228,074.00 |